Mitigate Risk By Being Courier Agnostic

By Gregory Stevens, Executive Director - Business Operations, Cryoport Systems

Among the many challenges COVID-19 has brought to light in all walks of life; formidable challenges abound with shipping critical, high value, temperature sensitive materials. And as expected, some logistic couriers are flourishing while others are floundering. The impact on key stakeholders, especially within cell and gene therapy, has been profound. The loss of critical and often irreplaceable material can be devastating; clinical programs can fail and worse yet, the outcome for immunocompromised patients can be lethal.

Cryoport Systems has grown leaps and bounds during the pandemic due to our ability to mitigate risk. One of the fundamental ways we accomplish this is by being courier agnostic. In short, we are not tied to any courier. Rather, we partner with over 30 different couriers.